Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
about
Telomeres, NAFLD and Chronic Liver DiseaseRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesHepatic progenitor cells in canine and feline medicine: potential for regenerative strategiesAging and liver diseaseReactive oxygen species and fibrosis: further evidence of a significant liaisonLipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cellsCellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.CDKN1A: a double-edged sword in fatty liver?Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver diseaseEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Cellular senescence drives age-dependent hepatic steatosis.17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing FeminizationSenescent human hepatocytes express a unique secretory phenotype and promote macrophage migrationHepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver diseaseTenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in miceChronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and FibrosisMultiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established BiomarkersThe P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitroDeoxyribonucleic acid telomere length shortening can predict the incidence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.Liver diseases and aging: friends or foes?Telomere and telomerase in chronic liver disease and hepatocarcinoma.Histone variants and lipid metabolism.Cellular senescence: a hitchhiker's guide.Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in miceThe Involvement of Acetaldehyde in Ethanol-Induced Cell Cycle Impairment.SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes.Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma.Liver disease in menopause.Liver physiology and liver diseases in the elderly.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.Hepatic toxicity caused by PLGA-microspheres containing usnic acid from the lichen C ladonia substellata (AHTI) during pregnancy in Wistar rats.Telomere, telomerase and liver disease.Cellular senescence: Implications for metabolic disease.Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression.A comprehensive approach to the molecular determinants of lifespan using a Boolean model of geroconversion.Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study.
P2860
Q26753037-83BFFA53-DD24-44ED-B5BB-428025E1103CQ26786129-A4345A85-1105-4479-8B9D-280A4B3606D7Q26823828-BC738418-14CE-400A-BE6C-8CC9985F0AD8Q26852595-093416F7-E278-4391-92AF-F0356DBE46A4Q28077930-A552E00C-8672-4A0E-9E26-7AF2CE5EF05BQ28538284-10FDA808-0DB2-4E77-A069-2F3ACD97DCAAQ30443462-85CB4623-E709-4B9F-BCB4-8558F58092A1Q33728881-87F955FD-D6B0-4791-B205-2AA573D8297EQ33728918-4935F424-205C-4524-A1C2-A4F426AAED87Q33755829-DFF31514-5DF0-451D-9A1F-C72530DF8331Q33810220-D29A7C94-1608-4559-B83E-E3EBFAEF9622Q34510747-F2AA34C2-68C6-49DC-B9BF-489252D39E87Q34750592-4BDB9355-06F6-4EF4-B464-4DC023CCD0FBQ35004683-99BE8183-F315-4245-A9CA-2D7FDE81A501Q35102322-0A6B8201-2768-4A0E-9197-26A9D56E0818Q35646392-928DA948-A26A-461E-A92C-81CFBD7AE2B2Q36197398-83FC756B-3976-417D-90A9-5D1D74D72CCEQ37051221-16FB1B10-44FF-4E66-AD08-8AF750C43781Q37059528-099C4034-9573-4A07-B80E-4A02A02E4CA9Q37677883-5095D21E-BAC7-4495-B1D8-DA1A624024D3Q38118358-61AA379C-3F48-48F7-A651-D70A34076D88Q38216014-05571C11-14BE-4A9D-B33D-DD2E61E452E5Q38252314-4C2838F2-B40F-45A7-8DC5-722052667435Q38359181-7312AA2F-C94C-4883-9E3C-5193DCA297B4Q38443228-B4FEC302-69EF-49F5-B60E-18381C3BED0AQ38780823-868EF817-E8EA-41CB-819E-0A35D4BB5FC9Q41565745-47D8083E-443C-4590-AB8D-87668B8E7AD6Q41962867-E63CE9A6-0EF9-43F3-A2EE-19DA6E2FC0EBQ42359764-4D53BB3A-96FE-4D37-879C-42E028A78575Q42780223-CAD94658-B7ED-4931-B80C-58EB9777D400Q47282821-5F2B870D-A525-4666-A1D0-DC1A01151247Q47676902-3EACC586-247A-4316-A047-AE057846FAB7Q47721991-D7DC6C83-916D-45D0-B613-70922B999224Q48355181-B53C5385-8F90-4B59-BB15-DEBA1D3586DEQ49069786-328DA854-7001-4FF7-ABD5-7B0A4D8DA4ABQ49565626-3EDFA2D0-752C-4450-91FF-C842F1BE38B2Q49614371-1AAA45C1-4B22-48BB-9547-063F0BDDE8CDQ53013442-56F2BFAA-FB7A-4DDF-9D69-BDB068734803Q53770256-34CFA98B-9A64-4AF7-9221-71F5899FB7D1Q55402006-8D83BC84-B294-4C70-819F-7210F3E12F12
P2860
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@en
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@nl
type
label
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@en
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@nl
prefLabel
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@en
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@nl
P2093
P50
P1476
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
@en
P2093
Graeme Alexander
Nick Coleman
Phaedra Tachtatzis
Rebecca Harvey
Sue Penrhyn-Lowe
Suman Verma
Susan E Davies
P304
P356
10.1016/J.JHEP.2012.10.031
P577
2012-11-08T00:00:00Z